522 related articles for article (PubMed ID: 25572557)
1. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.
Arima K; Ohta S; Takagi A; Shiraishi H; Masuoka M; Ontsuka K; Suto H; Suzuki S; Yamamoto K; Ogawa M; Simmons O; Yamaguchi Y; Toda S; Aihara M; Conway SJ; Ikeda S; Izuhara K
Allergol Int; 2015 Jan; 64(1):41-8. PubMed ID: 25572557
[TBL] [Abstract][Full Text] [Related]
2. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
[TBL] [Abstract][Full Text] [Related]
3. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
4. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
[TBL] [Abstract][Full Text] [Related]
5. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.
Nomura I; Goleva E; Howell MD; Hamid QA; Ong PY; Hall CF; Darst MA; Gao B; Boguniewicz M; Travers JB; Leung DY
J Immunol; 2003 Sep; 171(6):3262-9. PubMed ID: 12960356
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
[TBL] [Abstract][Full Text] [Related]
7. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model.
Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG
J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588
[TBL] [Abstract][Full Text] [Related]
8. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
10. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
[TBL] [Abstract][Full Text] [Related]
11. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.
Mashiko S; Mehta H; Bissonnette R; Sarfati M
J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611
[TBL] [Abstract][Full Text] [Related]
12. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
13. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice.
Nakai K; He YY; Nishiyama F; Naruse F; Haba R; Kushida Y; Katsuki N; Moriue T; Yoneda K; Kubota Y
Sci Rep; 2017 Sep; 7(1):12473. PubMed ID: 28963556
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
15. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
16. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
17. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
18. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes.
Shiraishi H; Masuoka M; Ohta S; Suzuki S; Arima K; Taniguchi K; Aoki S; Toda S; Yoshimoto T; Inagaki N; Conway SJ; Narisawa Y; Izuhara K
Allergol Int; 2012 Dec; 61(4):563-72. PubMed ID: 22918211
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Vandeghinste N; Klattig J; Jagerschmidt C; Lavazais S; Marsais F; Haas JD; Auberval M; Lauffer F; Moran T; Ongenaert M; Van Balen M; Dupont S; Lepescheux L; Garcia T; Härtle S; Eyerich K; Fallon PG; Brys R; Steidl S
J Invest Dermatol; 2018 Jul; 138(7):1555-1563. PubMed ID: 29474945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
